Evidence map›Paper›PMID 30218387›Full record

ArticleEuropean archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery2018

Role of leptin in allergic rhinitis during sublingual immunotherapy.

Yanhui Wen, Lifeng Zhou, Yuqiu Li, Zhengmin Li, Weijun Deng, Tao Zhang

Abstract read
PubMed Publisher
In one paragraph

Article in European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.5field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 23 citations in OpenAlex.

  1. Trial
  2. Article
  3. Review
  4. Review
  5. [The research progress of mechanism of allergen immunotherapy in allergic rhinitis].Lin chuang er bi yan hou tou jing wai ke za zhi = Journal of clinical otorhinolaryngology head and neck surgery · 2021
    Review
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 5 institutions in 1 country.

Yanhui WenDepartment of Otolaryngology, Guangzhou Overseas Chinese Hospital, Jinan University, No. 613 West Huangpu Avenue, Guangzhou, 610632, China.
Lifeng ZhouDepartment of Otolaryngology, Guangzhou Women and Children's Hospital, Guangzhou, China.
Yuqiu LiDepartment of Imaging, The Third People's Hospital of Dongguan, Dongguan, China.
Zhengmin LiDepartment of Otolaryngology, Boai Hospital of Zhongshan, Zhongshan, China.
Weijun DengDepartment of General Surgery, The Third People's Hospital of Dongguan, Dongguan, China.
Tao ZhangDepartment of Otolaryngology, Guangzhou Overseas Chinese Hospital, Jinan University, No. 613 West Huangpu Avenue, Guangzhou, 610632, China. zhangtaoent@sohu.com.ORCID http://orcid.org/0000-0002-3968-7538
Dongguan People’s Hospital · CNBoai Hospital of Zhongshan · CNGuangdong Province Women and Children Hospital · CNGuangzhou University of Chinese Medicine · CNJinan University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveIncreasing evidence suggests that leptin is upregulated during allergic reactions in the airway and related to the severity of disease in allergic rhinitis (AR). In this study, we aimed to investigate the expression of leptin during sublingual immunotherapy (SLIT) in AR patients.

methodsForty AR patients without obesity were recruited in this study. Twenty patients received house dust mite (HDM) allergen extract for SLIT and twenty patients received placebo randomly. Protein expression of leptin in serum and nasal lavage was tested by enzyme-linked immuno sorbent assay (ELISA) 1 and 2 years after SLIT treatment, respectively. Peripheral blood mononuclear cells (PBMCs) and human nasal epithelial cell were prepared and stimulated by recombinant leptin after 24 months' SLIT treatment and the induction of Th2 cytokines (IL-4/IL-5/IL-13) were detected by ELISA.

resultsSLIT treatment decreased the expression of leptin protein in serum and nasal lavage significantly compared with placebo group 1 and 2 years after SLIT treatment. Nasal leptin level was correlated to decreased Th2 response (IL-4/IL-5/IL-13) and enhanced Treg (IL-10/TGF-beat) response after 2 years' SLIT. We also found that SLIT decreased the ability of leptin in promoting Th2 cytokines expression by PBMCs and human nasal epithelial cell after 2 years' SLIT treatment.

conclusionChanges of leptin expression in serum and nasal lavage may be correlated with Th2/Treg regulation during SLIT. Our results suggested that leptin served as an important biomarker during SLIT.

Indexed as

AdolescentAdultCytokinesEnzyme-Linked Immunosorbent AssayFemaleHumansLeptinMaleMiddle AgedRecombinant ProteinsRhinitis, AllergicSublingual ImmunotherapyTreatment OutcomeYoung AdultCytokinesLeptinRecombinant ProteinsAllergic rhinitisLeptinSublingual immunotherapy

Identifiers

PMID30218387
OpenAlexW2891685555

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.